Abstract: A storage device includes a nonvolatile memory device; and a controller configured to, sequentially receive first read commands and a first write command, the first write command being associated with first write data, slice the first write command to generate a plurality of sub-commands, slice the first write data to generate a plurality of sub-data elements, and alternately transmit, to the nonvolatile memory device, at least one read command of the first read commands, and one sub-command of the plurality of sub-commands and one sub-data element of the plurality of sub-data elements.

Abstract: Disclosed are oxadiazole compounds and pharmaceutically acceptable salts thereof. The compounds and pharmaceutically acceptable salts thereof are specifically suitable for the treatment of neurological diseases such as epilepsy.

Abstract: The present invention relates to a stick formulation cosmetic composition for eye make-up comprising a fiber and a hectorite-based oil thickener, and a stick formulation cosmetic product manufactured using the composition. A cosmetic composition according to an aspect allows a fiber to attach to eyebrows, providing an excellent effect of making the eyebrows look full, and also has excellent sustainability and waterproof properties.

Abstract: The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same: wherein X, Z, R1 and R2 are as defined in the specification. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.

Abstract: A storage device includes a nonvolatile memory device; and a controller configured to, sequentially receive first read commands and a first write command, the first write command being associated with first write data, slice the first write command to generate a plurality of sub-commands, slice the first write data to generate a plurality of sub-data elements, and alternately transmit, to the nonvolatile memory device, at least one read command of the first read commands, and one sub-command of the plurality of sub-commands and one sub-data element of the plurality of sub-data elements.

Abstract: The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same: wherein X, Z, R1 and R2 are as defined in the specification. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.

Abstract: The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same: wherein X, Z, R1 and R2 are as defined in the specification. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.

Abstract: The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same: wherein X, Z, R1 and R2 are as defined in the specification. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.

Abstract: The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same: wherein X, Z, R1 and R2 are as defined in the specification. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.

Abstract: The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same: wherein X, Z, R1 and R2 are as defined in the specification. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.

Abstract: The present invention relates to a method of determining the position of a deep brain stimulation (DBS) electrode which finds the position of the DBS electrode with respect to a deep brain target region, by using a first volume data set containing information on the deep brain target region and a second volume data set containing information on the DBS electrode implanted toward the deep brain target region, and which includes: a first step of generating a subvolume of the deep brain target region from the first volume data set, and also generating a subvolume of the DBS electrode from the second volume data set; and a second step of overlapping and displaying the subvolume of the deep brain target region and the subvolume of the DBS electrode.

Abstract: The present invention relates to a method of determining the position of a deep brain stimulation (DBS) electrode which finds the position of the DBS electrode with respect to a deep brain target region, by using a first volume data set containing information on the deep brain target region and a second volume data set containing information on the DBS electrode implanted toward the deep brain target region, and which includes: a first step of generating a subvolume of the deep brain target region from the first volume data set, and also generating a subvolume of the DBS electrode from the second volume data set; and a second step of overlapping and displaying the subvolume of the deep brain target region and the subvolume of the DBS electrode.

Abstract: A plant for wastewater treatment is provided by an exemplary embodiment of the present invention. The plant for wastewater treatment includes a reactor into which wastewater and air flow into and depart from; multi-layer sludge separating portions, wherein pollutants in wastewater can be decomposed by increasing an amount of dissolved oxygen because upward moving time of intruded wastewater and air bubbles can be increased by including a reactor divided into upper and lower sides, and fluidity of wastewater may be improved by forming a residential space; and carriers located between the sludge separating portions and including a large amount of microbes, wherein wastewater treatment is performed by a biological reaction caused by contact between the carriers and wastewater.

Abstract: An apparatus and method for treating wastewater are provided. The method for treating wastewater includes: a pre-treatment step of removing impurities contained in high concentration wastewater and crushing the impurities using a crusher; a first aerobic treatment step of supplying wastewater containing organic acids to a first aerobic tank and injecting air to the first aerobic tank to be aerobically treated; an anaerobic treatment step of supplying the wastewater, from which excess organic acids are removed by the aerobic treatment, to an anaerobic tank to be anaerobically treated; a degassing step of supplying the wastewater treated in the aerobic and anaerobic treatment steps to a degassing tank to remove air and gas; and a post-treatment step of precipitating the wastewater aerobically treated using a solid-liquid separation tank, a pressure floatation tank or a precipitation tank.

Abstract: A plant for wastewater treatment is provided by an exemplary embodiment of the present invention. The plant for wastewater treatment includes a reactor into which wastewater and air flow into and depart from; multi-layer sludge separating portions, wherein pollutants in wastewater can be decomposed by increasing an amount of dissolved oxygen because upward moving time of intruded wastewater and air bubbles can be increased by including a reactor divided into upper and lower sides, and fluidity of wastewater may be improved by forming a residential space; and carriers located between the sludge separating portions and including a large amount of microbes, wherein wastewater treatment is performed by a biological reaction caused by contact between the carriers and wastewater.

Abstract: An apparatus and method for treating wastewater are provided. The method for treating wastewater includes: a pre-treatment step of removing impurities contained in high concentration wastewater and crushing the impurities using a crusher; a first aerobic treatment step of supplying wastewater containing organic acids to a first aerobic tank and injecting air to the first aerobic tank to be aerobically treated; an anaerobic treatment step of supplying the wastewater, from which excess organic acids are removed by the aerobic treatment, to an anaerobic tank to be anaerobically treated; a degassing step of supplying the wastewater treated in the aerobic and anaerobic treatment steps to a degassing tank to remove air and gas; and a post-treatment step of precipitating the wastewater aerobically treated using a solid-liquid separation tank, a pressure floatation tank or a precipitation tank.